Natural history and outcomes in drug‐induced autoimmune hepatitis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Hepatology Research

• Publication date

  2016-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/hepr.12532PMID 25943838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-induced liver injury.

  2016cited by this paper
• Auto immune hepatitis.

  2016cited by this paper
• Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature

  2016cited by this paper
• Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network

  2014cited by this paper
• Echinacea‐induced acute liver failure in a child

  2014cited by this paper
• Nitrofurantoin-Induced Hepatotoxicity: A Rare Yet Serious Complication

  2014cited by this paper
• Spectrum of statin hepatotoxicity: Experience of the drug‐induced liver injury network

  2014cited by this paper
• Autoimmune hepatitis.

  2013cited by this paper
• Nonsteroidal anti-inflammatory drug-induced hepatoxicity.

  2013cited by this paper
• Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

  2013cited by this paper
• OC-34 Clinical features and outcome of patients with drug-induced autoimmune hepatitis

  2012cited by this paper
• 486 IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) IN PATIENTS WITH PRE-EXISTING LIVER DISEASE: AN ANALYSIS OF THE CASES INCLUDED IN THE SPANISH DILI REGISTRY

  2011cited by this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE The Use of Liver Biopsy Evaluation in Discrimination of Idiopathic Autoimmune Hepatitis Versus Drug-Induced Liver Injury

  2011cited by this paper
• Seven cases of autoimmune hepatitis that developed after drug‐induced liver injury

  2011cited by this paper
• Drug induced liver injury and its relationship to autoimmune hepatitis.

  2011cited by this paper
• Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.

  2011cited by this paper
• Drug‐induced autoimmune hepatitis: Clinical characteristics and prognosis

  2010cited by this paper
• Autoimmune hepatitis triggered by nitrofurantoin: a case series

  2010cited by this paper
• Diagnosis and management of autoimmune hepatitis

  2010cited by this paper
• The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice.

  2009cited by this paper
• A case of valerian-associated hepatotoxicity.

  2008cited by this paper
• Echinacea-induced severe acute hepatitis with features of cholestatic autoimmune hepatitis.

  2008cited by this paper
• The impact of ethnicity on the natural history of autoimmune hepatitis

  2007cited by this paper
• Autoimmune hepatitis after treatment with fluvastatin

  2007cited by this paper
• Autoimmune hepatitis triggered by statins.

  2006cited by this paper
• Outcome of acute idiosyncratic drug‐induced liver injury: Long‐term follow‐up in a hepatotoxicity registry

  2006cited by this paper
• Herb and supplement use in the US adult population.

  2005cited by this paper
• Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome

  2005cited by this paper
• Factors Predicting Relapse and Poor Outcome in Type I Autoimmune Hepatitis: Role of Cirrhosis Development, Patterns of Transaminases During Remission and Plasma Cell Activity in the Liver Biopsy

  2004cited by this paper
• International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

  1999cited by this paper
• Hepatotoxicity of herbal remedies.

  1997cited by this paper
• Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

  1996cited by this paper
• Diclofenac induced hepatitis

  1993cited by this paper
• Sleep disorders. Liver damage warning with insomnia remedy.

  1993cited by this paper
• Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

  1993cited by this paper
• Hepatotoxicity of herbal remedies.

  1989cited by this paper
• Chronic Active Hepatitis and Severe Hepatic Necrosis Associated with Nitrofurantoin

  1980cited by this paper
• American Association for the Study of Liver Diseases

  1959cited by this paper

• British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis

  2025cites this paper
• Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification

  2025cites this paper
• Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database

  2025cites this paper
• Autoimmune hepatitis associated with statins: a retrospective study of pharmacovigilance databases and review of the literature.

  2025cites this paper
• Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study

  2025cites this paper
• Metabolic mysteries of copper dysregulation in Wilson disease

  2025cites this paper
• Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms

  2025cites this paper
• Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity

  2025cites this paper
• A case report of autoimmune hepatitis treated in a general practice clinic with delayed diagnosis.

  2024cites this paper
• Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use

  2023cites this paper
• Autoimmune Hepatitis in People Living with HIV: A Case Series and Review of Literature

  2023cites this paper
• Idiosyncratic DILI: Immunology in Cases with Evidence Based on RUCAM

  2023cites this paper
• Defining characteristics and long‐term prognosis of drug‐induced autoimmune‐like hepatitis: A retrospective cohort study

  2023cites this paper
• Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury

  2023cites this paper
• Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations

  2023cites this paper
• Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries

  2023influential citation
• Idiosyncratic DILI and RUCAM under One Hat: The Global View

  2023cites this paper
• Drug-induced autoimmune hepatitis: A minireview

  2022cites this paper
• Ceftriaxone-induced hepatotoxicity in patients with common medical infections in Qatar: A retrospective study

  2022cites this paper
• Side effects of statins-from pathophysiology and epidemiology to diagnostic and therapeutic implications.

  2022cites this paper
• Metabolic Syndrome as a Risk Factor for Idiosyncratic Drug-Induced Autoimmune Hepatitis (DIAIH) Following Nitrofurantoin Exposure

  2021cites this paper
• Drug Impairment and Liver Disease

  2021cites this paper
• Review Article Drug Impairment and Liver Disease

  2021cites this paper
• A Case of Autoimmune Hepatitis after Occupational Exposure to N,N-Dimethylformamide

  2020cites this paper
• Current and future perspectives in autoimmune hepatitis.

  2018cites this paper
• CD4+Foxp3+CD25+/- Tregs characterize liver tissue specimens of patients suffering from drug-induced autoimmune hepatitis: A clinical-pathological study.

  2018cites this paper
• Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection

  2018cites this paper
• Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use

  2018cites this paper
• The Saudi Association for the Study of Liver Diseases and Transplantation clinical practice guidelines for management of autoimmune hepatitis

  2018cites this paper
• Autoimmune Hepatitis-Induced by Drugs: a Challenging Diagnosis

  2017cites this paper
• Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long‐term outcomes

  2017cites this paper
• Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials.

  2017cites this paper
• Autoimmune hepatitis - update on clinical management in 2017.

  2017cites this paper
• Autoimmune hepatitis: current challenges and future prospects

  2017cites this paper
• Autoimmune Hepatitis-Induced by Drugs: a Challenging Diagnosis

  2017cites this paper
• The clinical phenotypes of autoimmune hepatitis: A comprehensive review.

  2016cites this paper
• Drug-induced liver injury.

  2016cites this paper
• Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature

  2016cites this paper